metipamide: no further info available 11/86
ID Source | ID |
---|---|
PubMed CID | 135086 |
CHEBI ID | 135441 |
MeSH ID | M0144176 |
Synonym |
---|
unii-n9q32yur4e |
n9q32yur4e , |
metipamide |
CHEBI:135441 |
hypotylin (tn) |
D08208 |
85683-41-6 |
benzoic acid, 3-(aminosulfonyl)-4-chloro-, 2-methyl-2-phenylhydrazide |
2-chloro-5-[(n-methylanilino)carbamoyl]benzenesulfonamide |
AKOS024344623 |
DTXSID00234964 |
2-chloro-5-((2-methyl-2-phenylhydrazino)carbonyl)benzenesulfonamide |
Excerpt | Relevance | Reference |
---|---|---|
" The results of our clinical trial showed that metipamide is an effective first-line antihypertensive agent, in that it combines satisfactory reduction of blood pressure with a low frequency of side-effects and a simple once-daily dosage regime." | ( Therapeutic monitoring of metipamide during antihypertensive therapy. Grafnetterová, J; Klíma, J; Kubelka, Z, 1989) | 0.83 |
Class | Description |
---|---|
sulfonamide | An amide of a sulfonic acid RS(=O)2NR'2. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |